safety of glp-1 receptor agonists A schematic overview agonists: classification, drug GLP-1 Receptor Agonists and Research
Description
doi:10.1016/j.cgh.2023.08.034 70
The introduction of GLP-1 RAs for pediatric obesity represents both an opportunity and a challenge
113 Patients with active UC and CD had higher amounts of bioactive GLP-2 than healthy controls, according to a study by Xiao et al
Titration of GLP-1RA based on the individuals response in weight and glycemic control is recommended
A., Bartels, E., Orskov, C., Ebert, R
Metabolic improvement with short-term, glucagon-like peptide-1 receptor agonist treatment does not improve cardiac diastolic dysfunction in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial
